Abstract
The main objective of the work was to develop and validate a stability indicating HPLC method for the determination of celecoxib and to perform forced degradation studies. The method was developed by Agilent HPLC with the column L11 (4.6 x 250mm, 5 µm), it has a mobile phase of monobasic potassium phosphate buffer [pH 3.0], methanol and acetonitrile in the ratio of 60: 30 : 10 v/v/v. The flow rate was set at 2.0 ml/min with a detection wavelength of 215nm using VWD detector. The method was validated for analytical parameters such as specificity, accuracy, precision, robustness and ruggedness as per ICH guidelines. The linearity was found to be in the range of 25-120 ?g/ml with a correlation coefficient value 0.9999. The precision is exemplified by relative standard deviation of 0.3%. Percentage mean recovery was found to be in the range of 97-99, during accuracy studies. The proposed method was found to be simple, accurate, precise, and robust and stability indicating HPLC method. Hence this method can be used for routine analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
